| 名稱 | FCGR2A/HEK293 |
| 型號(hào) | CBP74077 |
| 報(bào)價(jià) |  |
| 特點(diǎn) | FCGR2A/HEK293，凍存條件：90% FBS+10% DMSO； |
產(chǎn)品搜索
相關(guān)文章
- 國內(nèi)研究者Cell Research：韓春雨NgAgo有效
- 基于納米顆粒的組合免疫療法對(duì)致命性癌癥發(fā)起三重打擊
- FH標(biāo)準(zhǔn)品上新
- 黑色素瘤研究進(jìn)展一覽
- 腫瘤細(xì)胞調(diào)控關(guān)鍵因子和機(jī)制的研究講解
- IL36靶點(diǎn)藥物細(xì)胞篩選模型藥
- CYP2C19基因多態(tài)性用藥指導(dǎo)標(biāo)準(zhǔn)品
- CYP2C9基因多態(tài)性用藥指導(dǎo)標(biāo)準(zhǔn)品
- 自身免疫疾病潛力靶點(diǎn)——IL-5藥篩細(xì)胞模型
- Ep-CAM IHC質(zhì)控品上新
聯(lián)系我們
聯(lián)系人：蔣經(jīng)理
電話：4008750250
號(hào)碼：
手機(jī)：18066071954
地址：南京市棲霞區(qū)緯地路9號(hào)
Email： zhangxiangwen@cobioer.com
電話：4008750250
號(hào)碼：
手機(jī)：18066071954
地址：南京市棲霞區(qū)緯地路9號(hào)
Email： zhangxiangwen@cobioer.com
產(chǎn)品展示 / PRODUCTS
藥靶細(xì)胞株 > 腫瘤免疫細(xì)胞株 > CBP74077FCGR2A/HEK293
- 詳細(xì)內(nèi)容
FCGR2A/HEK293
| CBP74077 | |
| I. Background | |
| FCGR2A (FcγRIIa) is a Protein Coding gene. Diseases associated with FCGR2A include Cystic Fibrosis and Systemic Lupus Erythematosus. Among its related pathways are Innate Immune System and Microglia Activation During Neuroinflammation: Overview. | |
| II. Description | |
| Recombinant HEK293 cells constitutively expressing FCGR2A. | |
| III. Introduction | |
| Host Cell: | HEK293 |
| Expressed gene: | FCGR2A（FcγRIIa） |
| Stability: | 32 passages (in-house test, that not means the cell line will be instable beyond the passages we tested.) |
| Synonym(s): | FCGR2A |
| Freeze Medium: | 90% FBS+10% DMSO |
| Culture Medium: | DMEM+10%FBS+Hygromycin 100ug/ml |
| Mycoplasma Testing: | Negative |
| Storage: | Liquid nitrogen |
| Application(s): | Binding Assay,FACS |
| IV. Description of Host Cell Line | |
| Organism: | Human |
| Tissue: | Kidney |
| Morphology: | Epitheloid cell |
| Growth Properties: | Adherent |
| Ⅴ. Representative Data | |
Figure 1.Recombinant HEK293 cells constitutively expressing FCGR2A(FcγRIIa). | |
會(huì)員_a.png)